174 related articles for article (PubMed ID: 19120284)
1. The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice.
Wong FS; Hu C; Zhang L; Du W; Alexopoulou L; Flavell RA; Wen L
Ann N Y Acad Sci; 2008 Dec; 1150():146-8. PubMed ID: 19120284
[TBL] [Abstract][Full Text] [Related]
2. IDO mediates TLR9-driven protection from experimental autoimmune diabetes.
Fallarino F; Volpi C; Zelante T; Vacca C; Calvitti M; Fioretti MC; Puccetti P; Romani L; Grohmann U
J Immunol; 2009 Nov; 183(10):6303-12. PubMed ID: 19841163
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Krieg AM; Vollmer J
Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the innate immune responses in wild-derived inbred strains of mice.
Stephan K; Smirnova I; Jacque B; Poltorak A
Eur J Immunol; 2007 Jan; 37(1):212-23. PubMed ID: 17163447
[TBL] [Abstract][Full Text] [Related]
5. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
[TBL] [Abstract][Full Text] [Related]
6. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
[TBL] [Abstract][Full Text] [Related]
7. Insulin-dependent diabetes loci Idd5 and Idd9 increase sensitivity to experimental autoimmune encephalomyelitis.
Mayo S; Kohler W; Kumar V; Quinn A
Clin Immunol; 2006; 118(2-3):219-28. PubMed ID: 16301001
[TBL] [Abstract][Full Text] [Related]
8. TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response.
Ito T; Schaller M; Hogaboam CM; Standiford TJ; Chensue SW; Kunkel SL
Eur J Immunol; 2007 Oct; 37(10):2847-55. PubMed ID: 17853411
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes.
Liu M; Peng J; Tai N; Pearson JA; Hu C; Guo J; Hou L; Zhao H; Wong FS; Wen L
Diabetologia; 2018 Nov; 61(11):2333-2343. PubMed ID: 30094467
[TBL] [Abstract][Full Text] [Related]
10. TLR9 in health and disease.
Vollmer J
Int Rev Immunol; 2006; 25(3-4):155-81. PubMed ID: 16818370
[TBL] [Abstract][Full Text] [Related]
11. IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice.
Rajagopalan G; Kudva YC; Sen MM; Marietta EV; Murali N; Nath K; Moore J; David CS
Cytokine; 2006 Apr; 34(1-2):85-95. PubMed ID: 16740391
[TBL] [Abstract][Full Text] [Related]
12. Induction of diabetes in the RIP-B7.1 mouse model is critically dependent on TLR3 and MyD88 pathways and is associated with alterations in the intestinal microbiome.
Alkanani AK; Hara N; Lien E; Ir D; Kotter CV; Robertson CE; Wagner BD; Frank DN; Zipris D
Diabetes; 2014 Feb; 63(2):619-31. PubMed ID: 24353176
[TBL] [Abstract][Full Text] [Related]
13. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
14. The transmembrane domain directs TLR9 to intracellular compartments that contain TLR3.
Kajita E; Nishiya T; Miwa S
Biochem Biophys Res Commun; 2006 May; 343(2):578-84. PubMed ID: 16554027
[TBL] [Abstract][Full Text] [Related]
15. Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice.
Wu LH; Huang CC; Adhikarakunnathu S; San Mateo LR; Duffy KE; Rafferty P; Bugelski P; Raymond H; Deutsch H; Picha K; Ward CK; Alexoupolou L; Flavell RA; Mbow ML; Susulic VS
Metabolism; 2012 Nov; 61(11):1633-45. PubMed ID: 22607770
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.
McCall KD; Thuma JR; Courreges MC; Benencia F; James CB; Malgor R; Kantake N; Mudd W; Denlinger N; Nolan B; Wen L; Schwartz FL
Endocrinology; 2015 Feb; 156(2):453-61. PubMed ID: 25422874
[TBL] [Abstract][Full Text] [Related]
17. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes.
Kim YM; Brinkmann MM; Paquet ME; Ploegh HL
Nature; 2008 Mar; 452(7184):234-8. PubMed ID: 18305481
[TBL] [Abstract][Full Text] [Related]
18. Motor, Cognitive, and Behavioral Impairment in TLR3 and TLR9 Deficient Male Mice: Insights into the Non-Immunological Roles of Toll-Like Receptors.
Vargas-Calderón H; Ortega-Robles E; Rocha L; Yu P; Arias-Carrión O
Arch Med Res; 2024 Apr; 55(3):102985. PubMed ID: 38520880
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
